Igissinov Nurbek, Akshulakov Serik, Igissinov Saginbek, Moore Malcolm, Adilbekov Yerzhan, Gaitova Kamilla, Kissaev Yermek, Mustafina Meruert
Central Asia Cancer Institute, Astana, Kazakhstan.
Asian Pac J Cancer Prev. 2013;14(7):4181-6. doi: 10.7314/apjcp.2013.14.7.4181.
In the article were observed the epidemiological aspects of malignant tumors of the central nervous system (MT CNS) in Kazakhstan in a retrospective study for the years 2004-2011. The material of the study was consolidated accounting data of oncology centers on patients with MT CNS (C70-72) with first time established diagnosis. Calculated were crude, age, standardized (world standard), aligned and predicted incidence of MT CNS among both male and female populations. It was found that over the studied period, there were 4,604 cases of MT CNS. The average annual crude incidence rate of MT CNS in total population was 3.7±0.10/0000. Trends in aligned incidence rates in the whole country had a tendency to increase (T=+0.9%). Defined levels of morbidity MT CNS in the whole population in different regions of Kazakhstan: low up to 2.870/0000, the average from 2.87 to 4.450/0000 and high from 4.450/0000 and above on the basis of which was given the space-time estimate. Age and sex differences in MT CNS incidence were also clearly established.
在一篇文章中，通过对2004 - 2011年哈萨克斯坦中枢神经系统恶性肿瘤（MT CNS）的回顾性研究，观察了其流行病学方面的情况。研究材料为肿瘤中心关于首次确诊为MT CNS（C70 - 72）患者的综合统计数据。计算了男性和女性人群中MT CNS的粗发病率、年龄别发病率、标准化（世界标准）发病率、校正发病率和预测发病率。结果发现，在研究期间，共有4604例MT CNS病例。总人口中MT CNS的年平均粗发病率为3.7±0.10/10万。全国校正发病率呈上升趋势（T = +0.9%）。确定了哈萨克斯坦不同地区总人口中MT CNS的发病水平：低发病率地区低于2.87/10万，平均发病率地区为2.87至4.45/10万，高发病率地区为4.45/10万及以上，并据此进行了时空估计。MT CNS发病率的年龄和性别差异也得到了明确证实。
